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Abstract 
 
Background:  There has been a significant change in the types of substances consumed within 
English prison settings in the last eight years. There have been particular concerns regarding 
the acceleration in the use and availability of New Psychoactive Substances (NPS), mainly 
synthetic cannabinoids.  Although NPS were identified as a ‘problem’ in prisons in 2011, 
government responses emerged only in 2015.  As yet, there is no overarching policy document 
or strategy for dealing with NPS. This paper analyses the various strands of the response to 
NPS in prisons published from January 2015 to December 2016.   
 
Methods:  Drawing on Bacchi’s ‘What’s the problem represented to be’ framework, the ways 
in which the NPS ‘problem’ in prisons has been represented is analysed through a number of 
related policy texts including press releases, new legislative and regulatory measures, 
government documents and training package.  
 
Results:  From the various measures introduced to deal with the ‘problem’, NPS use is 
produced primarily as a law, order and control ‘problem’ requiring regulation, penalties and 
control, rather than a ‘demand problem’ calling for prevention, education, treatment and harm 
reduction or a ‘regime problem’ demanding greater emphasis and resources for purposeful 
activities such as education, training and work opportunities. This problematisation of drug use 
in prisons has a history dating back to the 1995 prison drug strategy and has become entrenched 
and reproduced within policy development over time. 
 
Conclusion:  The law, order, and control problematization blames the volatility of the 
substances and the individual prisoners who use them as key factors contributing to the current 
prison crisis, rather than as consequences of the wider practices, cultures, contexts, and 
conditions.  Multiple representations of the problem of NPS in prisons are needed in order to 
address the regime and structural issues which lead those imprisoned to use substances. 
 
Key words:  NPS, prisons, problematization, Bacchi, prison drugs policy, England 
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Introduction: new psychoactive substances in prisons 
 
  In the last eight years, new psychoactive substances (NPS) have become accepted as a 
distinct category of substances in their own right.  As Potter and Chatwin (2018) argue, some 
of these substances are not ‘new’ and hundreds of substances with different effects have been 
effectively lumped together into one catch-all category which has significant consequences for 
policy development and for the people who use them.    By the end of December 2017, the 
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) were monitoring 
more than 670 new psychoactive substances with 51 substances reported for the first time in 
2017 to the EU Early Warning System (EMCDDA, 2018a).   Recent European Drug Reports 
point to NPS use resulting in serious harms and playing increasing roles in hospital 
emergencies and some drug-induced deaths (EMCDDA, 2015a; 2016b; 2018c). Across the 
globe, there has been growing concern about how to develop effective legislation, policies and 
practice to deal with the harms associated with their use, supply and production (ACMD, 2011; 
UNODC, 2013; Home Office, 2014; EMCDDA, 2015b; 2016a). In fact, NPS have become one 
of the most pressing ‘problems’ preoccupying drug policy makers (Potter and Chatwin, 2018).  
Underpinning this policy interest are assumptions concerning the materiality of NPS in terms 
of their properties and effects in that they are perceived to be inherently dangerous, risky and 
harmful substances which produce predictable effects and results (Keane, 2002; Fraser, 2011).  
 
  Although the overall use of NPS in the UK has remained low in relation to other drugs, 
there is increasing concern among policy makers and practitioners about problem use and 
harms within some communities experiencing high levels of poverty, deprivation and social 
disadvantage (DrugScope, 2014; Shapiro, 2016) and within some risk groups (EMCDDA, 
2016a; 2017).  For example, the increased use of NPS among established populations of people 
with heavy drug use and among emerging groups of vulnerable young people has been 
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highlighted through research in several European countries (see Grund et al, 2016; Blackman 
and Bradley, 2017; Alexandrescu, 2017).  These substances have gained some popularity in 
specific populations including participants in nightlife settings, men who have sex with men, 
people who inject drugs, homeless and prison populations (EMCDDA, 2016a; 2017; 2018b; 
Pirona et al, 2016; Ralphs et al, 2017; Ralphs and Gray, 2018).   
 
  In Britain, there has been a significant change in the types of substances consumed by 
criminal justice populations, particularly within prison settings in the last eight years. In a 
report by HM Inspectorate of Prisons (HMIP) (2015) on the changing patterns of substance use 
in adult prisons, there were concerns regarding the acceleration in the use and availability of 
NPS (particularly synthetic cannabinoids known as ‘Spice’ and ‘Black Mamba’).  The report 
highlighted bullying and violence which was seen to be associated with the NPS market, acute 
health episodes requiring Accident and Emergency attendance and NPS-linked deaths.  
Violence, bullying and adverse health effects have also been documented in research studies 
(Ralphs et al, 2017; User Voice, 2016).  The HM Inspectorate of Prisons concluded (2015:7) 
that, ‘NPS have created significant additional harm and are now the most serious threat to 
safety and security of the prison system that our inspections identify’.  The Rehabilitation for 
Addicted Prisoners Trust (RAPT), a drug treatment agency with longstanding expertise of 
delivering treatment in prisons, expressed concern that ‘the situation on the ground is 
developing more rapidly than the sector is able to respond, and it is undermining good order 
and discipline in prisons’ (RAPT, 2015: 3).  This paper is concerned with analyzing the initial 
policy response to the issues raised by NPS in prisons from January 2015 to December 2016. 
In 2013-14, 34% of male prisons reported issues with synthetic cannabis and this figure 
rose to 64% in 2014-15 (HMIP, 2015).  In England and Wales, the number of incidents where 
NPS were found by prison staff increased from 136 in 2011 to 4,261 in 2015 (Smith, 2016).  
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Synthetic cannabinoids were the second most commonly used drug (10%) within prisons after 
cannabis (13%) (HMIP, 2015). Research focused on synthetic cannabinoids has been 
undertaken by a few organisations and researchers.  For example, a survey of prisoners 
conducted by User Voice (2016) found that synthetic cannabinoids (ie. Spice) were the most 
popular drugs of choice in prison reported by one-third (33%) using them in the last month, 
much greater than use of heroin (8%), heroin substitutes (14%) and cannabis (14%). However, 
estimates from discussions with prisoners put the figures for Spice use much higher from 40% 
to 90% (User Voice, 2016), 80% to 90% in one English prison (Ralphs et al, 2017) and national 
estimates from 60% to 90% of the prison population in England and Wales (Centre for Social 
Justice, 2015).   
Synthetic cannabinoids are known to be popular in prisons because they are 
undetectable by routine mandatory drug testing (MDT), do not have a distinctive ‘drug’ smell, 
easy to conceal, relatively cheap to purchase, help to relieve the boredom and monotony of 
prison life, offer an altered state of reality and are perceived not to be ‘illegal’ by prisoners 
(Lynch, 2015; Baker, 2015; Reuter and Pardo, 2016; Ralphs et al, 2017; Public Health England, 
2017). Research by Ralphs et al (2017) uncovered a thriving and lucrative market around 
synthetic cannabinoids with huge profit margins for those involved in dealing, effectively 
replacing the traditional drugs market in prison.  Spice has been described by some prisoners 
as a ‘bird killer’ (‘bird lime’ is Cockney rhyming slang for ‘prison time’) in that they believe 
it helps their sentences go faster by relieving the boredom of prison life and inducing relaxation 
(Baker, 2015; User Voice, 2016). There have also been reports that vulnerable prisoners were 
being used as “Spice Pigs” or “Mamba Muppets” to test batches of the substance to assess 
effects and safety and for the entertainment of other prisoners (HMIP, 2015; Prison and 
Probation Ombudsman, 2015).  According to the Prisons and Probation Ombudsman (2017), 
64 deaths in custody were associated with NPS use between June 2013 and April 2016.  In 
  5 
September 2015, the Prison Officers’ Association wrote to the Chief Coroner for England and 
Wales to express concern about NPS-related deaths in prison (Lynch, 2015).  
Although NPS were identified as an issue in British prisons by the HM Inspectorate of 
Prisons in 2011, national prison guidance emerged only in 2015. The initial Ministry of Justice 
response to NPS in prison was ‘paralysis’, mainly because MDT procedures could not detect 
these new substances (McBride, 2016).  Similar to the initial responses to NPS availability and 
use in the community (EMCDDA, 2016a), the reactions in British prisons to date have been 
mainly regulatory.  For example, in January 2015, the Ministry of Justice (2015) introduced a 
‘crackdown’ on NPS supply and use in prisons, involving new penalties for prisoners who use 
these substances and security measures to detect and eradicate supply.  In May 2016, the 
Psychoactive Substances Act banned any substance that has a psychoactive effect and 
introduced new offences including production, supply, possession with intent to supply, 
importation and exportation. The Act makes a distinction between the community and custodial 
settings in relation to possession.  In the community, possession for personal use is not an 
offence, but possession in prisons and other custodial institutions is an offence.  A toolkit and 
associated training package was developed by Public Health England (PHE) to support 
custodial, healthcare and substance use staff in dealing with NPS in prisons (Lynch, 2015; 
Public Health England, 2015). From November 2015 to May 2016, 32 training events took 
place with a total of 650 participants (Public Health England, 2017). 
The response to NPS in prisons is not located in a single document, instead there are 
several different strands including press releases, new legislative and regulatory measures, and 
a PHE toolkit/training package for prison staff.  The aim of this paper is to analyse these various 
strands of the initial response to NPS in prisons that emerged from January 2015 to December 
2016.  It employs the ‘What’s the problem represented to be’ (WPR) framework developed by 
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Carol Bacchi (2009) to analyse the ways in which NPS have been problematized and 
represented thus far in policy-related texts.  The next section of the paper will explain Bacchi’s 
framework in greater detail and the methodology employed in this analysis. 
 
Conceptual framework and methodology 
Influenced by Foucault, the ‘What’s the problem represented to be?’ (WPR) approach 
is a post-structural framework developed by Carol Bacchi to analyse responses to policy 
‘problems’ (Bacchi, 2009; 2012a; 2012b; Bacchi and Goodwin, 2016). It is increasingly being 
applied to understand the ways in which drugs issues are problematized and represented in 
policy and other texts (see Fraser and Moore, 2011; Lancaster and Ritter, 2014; Fraser et al, 
2014; Seear and Fraser, 2014; Martin and Aston, 2014; Lancaster et al, 2015a; 2015b; Piennar 
and Savic, 2016). Although her framework has not been used as extensively in the areas of 
prisons and criminal justice policy, a notable exception is the work of Walker et al (2018) 
which explored how the ‘problem’ of drug use was represented in Australian prison drugs 
policy (ie. Identified Drug User Program - IDUP) and its effects on young men in prison and 
their families.   
Policies claim to be the solutions to problems that exist and the WPR approach 
challenges this assumption.  Bacchi’s starting point for any policy response is to ask: ‘What is 
the problem represented to be, for which this policy is the answer?’ (Bacchi, 2009; 2012a).  
This approach shifts the focus from ‘problem solving’ to ‘problem questioning’. Policies or 
policy proposals constitute or produce particular representations of problems. Therefore 
governments are not reacting to ‘problems’, but ‘active in the creation (or production) of policy 
‘problems’ (Bacchi, 2009:1).  Identifying and exploring the implied ‘problems’ within policy 
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proposals enables an understanding of the ways in which particular representations of problems 
are crucial to the processes and practices of governance.  Problematisations are therefore 
integral to the policy.  As Bacchi (2009: xi) argues, ‘we are governed through 
problematisations, rather than through policies’, thus challenging the view that policies address 
problems. The constitution or representation of ‘problems’ matters because it impacts on how 
the issue is discussed, how the people involved are treated and how they are evoked to think 
about themselves (Bacchi, 2009; 2012b). 
Bacchi’s framework puts forward six interconnected questions in relation to policies or 
policy proposals and then asks analysts to apply the set of questions to their own problem 
representations: 
1) What’s the ‘problem’ represented to be in a specific policy? 
2) What presuppositions or assumptions underlie this representation of the ‘problem’? 
3) How has this representation of the ‘problem’ come about? 
4) What is left problematic in this problem representation?  Where are the silences? 
Can the ‘problem’ be thought about differently? 
5) What effects are produced by this representation of the ‘problem’? 
6) How/where has this representation of the ‘problem’ been produced, disseminated 
and defended?  How could it be questioned, disrupted and replaced? 
Step 7: Apply this list of questions to your own problem representations 
(Bacchi, 2009: xii) 
 
For Bacchi and Goodwin (2016: 17), policy is defined ‘in an expansive sense to include both 
the activities of state institutions and of other agencies and professions involved in maintaining 
social order’. They argue that policy texts can include a wide range of documents beyond the 
traditional written policy or strategy document such as legislation, bills, speeches, media 
statements and organizational reports, all of which are relevant to this analysis. 
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In order to interrogate the problem representations of NPS use in English prisons, 
several documents published from the beginning of 2015 to the end of 2016 were analysed (see 
Table 1 for a timeline of the documents).  As discussed above, this includes the press release 
from the Ministry of Justice announcing the new crackdown on NPS in prisons, the new 
measures for testing and supply reduction through the Criminal Courts and Justice Act 2015 
and Serious Crime Act 2015, the new regulatory framework introduced by the Psychoactive 
Substances Act 2016, the toolkit produced by Public Health England to raise awareness 
amongst staff in prisons, and the proposals in the White Paper on Prison Safety and Reform.  
At the time of writing, there was no holistic national strategy or policy document for dealing 
with NPS in prisons.  The HM Inspectorate of Prisons (2015) argued that the response to NPS 
in prisons has been ad hoc, inadequate and inconsistent across the prison estate.  
 (Insert Table 1 about here) 
Drawing on Bacchi’s framework, her first four questions were used as tools for 
analyzing the problem representations contained within the documents.  As Bacchi (2009: 101) 
argues ‘every question need not always be addressed in every analysis, although it is useful to 
keep the full set of questions in mind.’ The first section of the paper explores questions 1 and 
2 of Bacchi’s framework and examines the ways in which the ‘problem’ of NPS use is 
represented in the various strands of the response and the assumptions underpinning these 
representations. The second section explores question 3 focusing on the processes and history 
behind these representations of the ‘problem’.  The third section explores question 4 and 
examines the silences within the problem representations and suggests alternatives ways of 
thinking about the ‘problem’. 
 
  9 
NPS in prisons represented as a law, order and control ‘problem’ 
Taken together, the policies which emerged around NPS use in prisons during 2015-
2016 represented these substances as predominantly a ‘problem’ for law, order and control 
with a focus on disrupting and eradicating supply in prisons and punishing those caught dealing 
and using them.  The Ministry of Justice (2015) press release outlining the response to NPS in 
prison was entitled, ‘New crackdown on dangerous legal highs in prison’.  The discourse 
surrounding the response to NPS emphasised the ‘get tough’ approach highlighting the 
‘dangerousness’ of the substances which required a ‘crackdown’ and ‘zero tolerance’ approach.  
The ways in which NPS are problematized implies that existing approaches were ‘soft’ and 
‘lenient’ due to the lack of tools and technology to detect and control supply and powers to 
punish those prisoners using and dealing NPS in prison.  In the press release, Chris Grayling, 
the then Minister for Justice stated: 
No one should be under any illusion how dangerous the abuse of any drug is.  We are 
determined to make sure governors have every power at their disposal to detect supply, 
punish those found using or dealing, and enforce a zero tolerance approach. (Ministry 
of Justice, 2015: 1) 
The security and prevention measures included training specialist dog teams to detect synthetic 
drugs; a monitoring project to analyse urine samples and drug seizures for the presence of 
synthetic, prescription and other controlled drugs; and awareness campaigns to warn prisoners 
and visitors of the sanctions if they bring synthetic drugs into prisons.  The strategy aimed to 
equip prison governors with new powers (including a reminder of existing powers) for 
detection and punishment.  The punishment options included prosecution and further sentence, 
additional days in prisons, segregation, movement to a higher security prison, removal of 
privileges, forfeiture of earnings and closed visits.   
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During 2015-2016, various pieces of legislation introduced new offences and powers 
surrounding the use and supply of NPS in prisons.  The Serious Crime Act 2015 made it an 
offence to throw any article or substance into a prison (ie over or through a boundary of the 
prison), including all legal and illegal substances.  Here, the ‘problem’ is represented to be the 
couriers of the substances and therefore a supply issue. The Criminal Courts and Justice Act 
2015 introduced new powers to specify any substance/product (i.e. not a controlled drug under 
the Misuse of Drugs Act 1971) for which a prisoner may be required to provide a sample for 
testing.  This new legislation allowing for the testing of these substances would assist the prison 
authorities in both identifying and punishing prisoners using NPS. The Psychoactive 
Substances Act 2016, introduced after this initial ‘crackdown’ on NPS in prisons, makes a clear 
distinction between possession in the community and in ‘custodial institutions’ (refers to 
prisons, institutions and secure settings for young offenders, immigration removal centres and 
facilities, and Armed Forces custody premises).  In the community, it is not an offence to 
possess NPS, while in prisons it is an offence, therefore producing a clear binary between the 
prison and community under the new Act.   
The assumptions underlying these representations of the ‘problem’ is that NPS in 
prisons need controlling and regulating in the same ways that other ‘illegal’ substances are 
controlled and criminalised.  By removing the legal/illegal binary and closing the gap between 
the two categories of substances, the assumption is that prisoners will be deterred from using 
and dealing these substances because they will now be sanctioned and punished.  Underpinning 
this strategy is the assumption that prisoners will make the ‘right choice’ by calculating and 
recognizing the increased risk of getting caught and punished for use and supply.   
Prisoners should be very clear – if they think they can get away with using these 
substances, they need to think again.  And the same applies to those who are the 
suppliers, whether they’re inside or outside the prison gates. (Justice Secretary, Chris 
Grayling quoted in Ministry of Justice, 2015: 1) 
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This denies the agency and rationality of prisoners who actively choose to use drugs for 
pleasure or as a way to cope with or alleviate the ‘pains of imprisonment’ (Sykes, 1958) or who 
choose to become involved in dealing to gain financial power, status, social and personal 
identities and social networks in prisons (Crewe, 2005; 2006; Mjaland, 2016).  In their analysis 
of the Identified Drug User Program in Australian prisons, Walker et al (2018) also identify 
this underlying logic of deterrence and rational choice or that increased control and punishment 
for drugs involvement will affect the decision making of young men imprisoned and that they 
will weigh up the risks, effort and rewards and ‘choose’ not to use drugs in the first place or to 
stop using drugs and enter treatment.  These problem representations simultaneously produced 
those imprisoned as ‘rational’ and ‘choosing’, but also as ‘untrustworthy’ and ‘deserving of 
punishment’ and these subjectivities had harmful effects for the young men and their families 
including increasing tension and violence, prisoners switching to other drugs to avoid 
detection, increasing health-related harms and deterrence of visitors.  These entrenched 
problem representations have implications for policy and practice by limiting how the drugs 
‘problem’ is conceptualized and by closing down alternative ways of understanding prison 
drug use and policy options, such as improving prisoners’ access to prescribed medication to 
reduce physical and mental suffering; improving and maintaining family and social ties to 
increase social capital and financial stability post-release and employing incentive-based 
programmes, rather than punishment based approaches (Walker et al, 2018). 
The 2016 White Paper on Prison Safety and Reform reinforced and embedded these 
representations of the ‘problem’ as being the lack of control and regulation of the substances, 
inadequate tools and technology to detect and block the substances and the inability to punish 
prisoners who are using and dealing them.  The evolving market in NPS and their use were 
viewed as ‘the most pressing threats to security in prisons’ (Ministry of Justice, 2016a: 10).  
The main response was to ‘redouble…efforts to tackle this challenge with the aim of 
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eradicating illicit drug use in prisons’ (Ministry of Justice, 2016a: 46).  It reiterated measures 
to enhance drug testing; to introduce legislation to allow new tests for psychoactive substances 
and to make it a criminal offence to smuggle them into prison; to secure the perimeters of 
prisons; to improve searching capability to search both staff and prisoners; to reduce 
opportunities for visitors to smuggle drugs in prisoners; to explore drug detection technologies 
(ie. body scanners and drug trace detectors); to improve intelligence sharing between agencies 
and to examine technologies to detect and block drones. New Prison League Tables were 
proposed which would introduce drug tests on entry and exit to prison and track the average 
rate of positive results from random drug tests to measure ‘health progress’ as a performance 
indicator (Ministry of Justice, 2016a); however, it is vague what ‘progress’ is being measured 
and there are no specific indicators on drug treatment outcomes.  Although MDT is represented 
mainly as a supply side and deterrence measure, it could also be represented in demand 
reduction terms where prisoners are identified as needing help through testing and referred into 
treatment.  Within the document however, the emphasis on demand reduction is secondary to 
supply reduction and enforcement measures. Few new resources were made available for 
treatment activities.  Alternative options, such as partnership working and better use of existing 
resources, were to be considered (Ministry of Justice, 2016a: 47).  
Alongside the introduction of new regulatory and punitive responses to deal with NPS 
in prisons, a toolkit and training package on NPS was developed for custodial and healthcare 
staff and drug and alcohol workers (Public Health England, 2015). The format of the toolkit is 
mainly the provision of information and includes sections on definitions and categories of NPS, 
the law, prevalence data, reasons for the popularity of NPS, challenges for healthcare staff and 
the wider prison regime, and the management of acute and chronic adverse effects.  Within this 
problematisation, NPS in prisons is represented as a training, knowledge and competence 
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‘problem’ for prison-based staff. The assumption is that the provision of information will deal 
with the effects and contain and control the ‘problem’ of NPS. 
The ‘crackdown’ on NPS in prisons assumes that the ‘problem’ is one of lack of control 
over these substances and the prisoners using them. The effects of synthetic cannabis are 
described as volatile, variable, unstable, unpredictable, but also as acute, adverse and harmful. 
Similar to the work of Fraser and Moore (2011) and Barratt et al (2017) on drug effects, NPS 
are constituted as an unknown quantity, but also as inherently harmful and dangerous.  Potter 
and Chatwin (2018: 332) argue that treating NPS as a distinct category of drugs obscures the 
differences within the NPS category and the similarities between NPS and existing illicit 
substances.  The NPS toolkit lists a number of ‘extreme effects’ of synthetic cannabinoids 
including ‘convulsions, bizarre behaviour, temporary paralysis, rapid heart rate, aggression and 
psychosis’ (PHE, 2015: 19) and points to the challenges for the prison regime including ‘the 
need to restrain and control prisoners behaving abnormally or dangerously’ (PHE, 2015: 21).  
The ‘problem’ of NPS use is seen to lodge in the substances themselves (Fraser and Moore, 
2011) which are described as ‘dangerous’ and linked to the increasing levels of violence within 
the prison system.  Unlike the drugs traditionally preferred in prisons, such as cannabis or 
opiates, which produce sedative and calming effects (Boys, 2002), the effects produced by NPS 
are taken for granted, specifically that all prisoners become unpredictable, uncontrollable and 
violent under the influence: ‘…these substances seem to be a part of the problem around 
increasing violence in our prison estate’ (Justice Secretary, Chris Grayling in press release, 
Ministry of Justice, 2015). One consequence of this representation of NPS, particularly 
synthetic cannabis, is that it has been directly linked to the increasing levels of violence and 
unrest in prisons.  The 2016 White Paper suggests that ‘the increase in violence has in part been 
fueled by the recent flood of dangerous psychoactive drugs into our prisons’ (Ministry of 
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Justice, 2016a: 7).  The use of NPS has also been blamed for the lack of purposeful activity 
and good relationships between prisoners and prison staff: 
Dealing with the effects of these substances has made it more difficult for many prisons 
to run full and purposeful regimes, occupying prisoners in activity to help their journeys 
to reform.  It has made it more difficult for staff to build constructive relationships with 
prisoners, through which they can combine supervision with helping to change their 
behaviour and attitudes.  (Ministry of Justice, 2016a: 41) 
In the context of reductions in frontline operational staff from 29,660 in 31 March 2012 to 
23,080 on 31 March 2016, the use of NPS and the increasing levels of violence in prison were 
also blamed for the difficulties in retaining existing staff and the need to recruit more staff. 
While it was right to seek to operate prisons more efficiently, the destabilizing effect of 
changes in the operating environment, such as the introduction of new psychoactive 
substances – described as a ‘game-changer’ by the Prisons and Probation Ombudsman 
– means we must now reconsider staffing levels.  (Ministry of Justice, 2016a: 41) 
In the latter part of 2016, the prison system was frequently referred to as being in a state 
of ‘crisis’ both from those within the system and external commentators (see for example, 
Cavendish, 2016a; Crook, 2016; House of Commons Debates, 2016; Prison and Probation 
Ombudsman, 2017). The increasing violence against staff and between prisoners, the 
increasing rates of self-harm and suicide and unrest (including full scale riots at Bedford and 
Birmingham prisons) were attributed partly to the use of Spice and the volatile effects it 
produced (HM Chief Inspector of Prisons, 2016a; 2016b; 2017a; 2017b).  In an interview after 
his term as HM Chief Inspector of Prisons had ended in 2016, Nick Hardwick suggested there 
was a clear link between NPS and violence: 
It’s important not to be under any doubt whatever about the havoc NPS and other drugs 
cause. You have people pushing them and the debt that is created as a result of the 
drugs trade in prison leads to violence, it leads to people feeling very insecure, self-
harming and so on. There is a direct link between drug availability and violence.  I 
think NPS are one of the major threats to the stability and security of the prison system 
at the moment.  (Cavendish, 2016b) 
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From the strategies proposed within the various policy statements and documents from 
2015-2016, NPS use was produced primarily as a ‘supply’ and ‘enforcement problem’ 
requiring regulation, penalties, and control, rather than a ‘demand problem’ requiring 
prevention, education, treatment, and harm reduction. The outcome of this problem 
representation has been a punitive regulatory approach, bringing NPS in line with the response 
to traditional ‘illegal’ drugs in prisons.  The aim of policy makers is to make them equivalent 
reducing the binary between illegal/legal and thus enabling control and regulation of these new 
substances.  The supply reduction and punitive response emerged first, followed by the 
emphasis on providing staff with information and training and the promise of greater focus on 
prevention, treatment and harm reduction for the future.  This temporal order to the problem 
representations and emerging strategies have powerful historical antecedents which will be 
explored in the next section. 
Continuity with past problem representations and drug policies in prisons 
The goal of Question 3 in Bacchi’s framework is to explore how a current problem 
representation has come to be or to trace its history over time (Bacchi, 2009).  In this case, the 
aim is to illuminate the processes that allowed for the law and order problem representation to 
take shape and assume dominance in relation to NPS in prisons in the current period. The 
response to NPS during 2015 to 2016 has clear continuities to past problem representations and 
developments in prison drugs policy which have been dominated historically by a focus on 
regulation, security and punishment, rather than education, treatment and harm reduction 
(Duke, 2003). A clear example was the first prison drugs strategy published in 1995 (HM 
Prison Service, 1995) where drugs in prison were represented as control, order and discipline 
‘problems’.  This problem representation was linked to the increasing populist punitive rhetoric 
around crime, drugs and prisons at the time (Bottoms, 1995).  Similar to the current period, the 
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prison system was considered to be in a ‘crisis’ of containment and control with an increasing 
prison population, overcrowding, and disturbances (Morgan, 1997).  Michael Howard, the then 
Home Secretary, advocated the idea that ‘prison works’ on deterrent and incapacitative grounds 
and announced a ‘crackdown’ on drugs in prison, echoing the current policy discourse of 
‘crackdowns’ and the constitution of NPS as a law and order ‘problem’. At the Conservative 
Party Conference in 1993, Howard argued, 
Prison works….I am particularly appalled by the drug taking in our prisons. This is not 
something we can tolerate.  It is possible to test prisoners for drug use.  We haven’t 
been doing it up to now; we will be doing it in the future. 
The 1995 strategy introduced MDT for the first time, enhanced security measures to reduce 
supply, and punishments for the use of drugs within prisons. 
Reducing the level of drug use became one of the strategic priorities of the Prison 
Service and would be monitored by a new performance indicator measuring the number of 
positive tests.  The aim of this technological solution was to attempt to impose order on a 
problem which was perceived to be spiraling out of control (Duke, 2003).  Similar to the current 
response to NPS in prisons, the response was underpinned by faith in the deterrent effect of the 
measures and the logic that prisoners would weigh up the risks and benefits of taking drugs in 
prisons and decide the risks and sanctions of getting caught through the new security and testing 
procedures were too great.  This confidence in the deterrent effect of these initiatives failed to 
take account of the reasons people choose to use drugs in prison. Although treatment, 
rehabilitation and harm reduction were mentioned in the 1995 strategy, the proposals were 
vague.  There was no universal treatment provision across the prison system, although a few 
pilot drug treatment programmes were introduced.  Within the strategy document, the new 
control, testing and security elements were presented much more explicitly with greater 
definition and detail compared to the treatment, rehabilitation and harm reduction elements 
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which were much less explicit, detailed and concrete (Duke, 2003).  Moreover, MDT and the 
security initiatives were universal requirements across the prison system which were backed 
up by central funding and clear deadlines for implementation, while treatment and harm 
reduction initiatives were to be established through guidelines, which would be subject to local 
decisions, resources and timetables. The punitive political context surrounding crime and 
punishment and the growing emphasis on managerialism ensured that the 1995 strategy was 
dominated by punitive, but measurable mechanisms such as MDT and increased security 
(Seddon, 1996).  This emphasis on testing as a performance indicator of progress is also a key 
feature of the current response to NPS. 
The review of the 1995 drug strategy highlighted the imbalances between punishment 
and treatment.  Although MDT and the various supply reduction measures were seen as 
generally successful in meeting their objectives, the review indicated that treatment provision 
required more fundamental improvements in terms of expansion, throughcare, staff training 
and inclusion of certain groups (HM Prison Service, 1998a).  Within the 1998 prison drug 
strategy, the ‘problem’ of drugs in prisons was represented in a multitude of ways.  In 
particular, it was represented more as a demand ‘problem’ than in the previous policy 
document.  The 1998 strategy placed greater emphasis on treatment provision, education for 
young offenders, throughcare, discrimination between dealers and users and between less 
harmful and more damaging drugs, and identifying strategies to engage short-term and remand 
prisoners (HM Prison Service, 1998b); however, the overall punitive framework for delivering 
the strategy where those who use drugs are punished remained intact (Duke, 2003).  Since 
1998, treatment was further expanded through resources made available via the National 
Treatment Agency, but also converged with the control and security aspects of the drugs 
strategy which were further enhanced and strengthened in order to fulfill the goals of crime 
reduction and public protection (Duke and Kolind, 2017). 
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The initial responses to NPS in prisons during 2015-2016 mirror the response to drugs 
during the mid to late 1990s with the introduction of ‘crackdowns’, testing, and punishments 
for substance use.  In both time periods, these responses are based first and foremost on the 
representation of drugs as law, order and control ‘problems’ in prisons.  Representing drugs as 
a demand ‘problem’ appeared later following a comprehensive review of the policy based on 
the results of commissioned research in the earlier period.  However, constituting NPS and 
drugs as demand ‘problems’ remain secondary within an overarching problematisation of law, 
order and control.  The problematisations and the temporal order in which they have been 
invoked have become entrenched within policy development cycles over time.  In many ways, 
the law and order problem representation could be viewed as an easy, ‘off the shelf’ response 
to the complex and multi-faceted issue of substance use in prisons.  However, this problem 
representation is not inevitable and can be disrupted by representing the problem in alternate 
ways that lead into different responses, policies and solutions.  These alternatives will be 
explored in the next section. 
 
Alternative Representations:  NPS use as a demand ‘problem’ and regime ‘problem’ 
Bacchi (2009: 13) asks us to consider the limits underlying particular problem 
representations by exploring what fails to be problematized, the silences within representations 
and how policies are constrained by the ways in which they present the problem. Alternative 
representations, issues and perspectives need to be examined. The constitution of NPS in 
prisons as predominantly a law, order and control ‘problem’ does not engage with the 
fundamental question: ‘why do prisoners take these substances in prison?’.  It was assumed 
that prisoners were using NPS in prisons because there was no deterrent and they were able to 
‘get away with it’ (Ministry of Justice, 2015). The main critique of such deterrence approaches 
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is that they fail to address the underlying causes of behaviour (Bacchi, 2009).  It is important 
to explore the cultures and contexts that promote the use of different substances within prisons.  
Producing NPS use as a law, order and control ‘problem’ means that the reasons prisoners use 
drugs are under-examined, silenced and subsequently not addressed.  
Drug use in prisons can be explained through both intra-institutional and extra-
institutional circumstances (Duke and Kolind, 2017).  Intra-institutional explanations focus on 
how drug use is a response to the pains of imprisonment (Sykes, 1958), a way of coping and 
self-medication. Drugs are often used to deal with the boredom and monotony of prison life.  
As research has shown, drugs are used to manipulate and re-order time, aid sleep and cope with 
sentences (Cope, 2003) and synthetic cannabinoids have been described as a ‘bird killer’ (User 
Voice, 2016).   An alternative problem representation of NPS use in prisons is that daily 
regimes in prison are inadequate and not engaging prisoners in meaningful activities.  The 
overall culture, context and conditions of the prison environment need to be considered in order 
to understand substance use.  For example, time out of cells undertaking ‘purposeful activity’ 
such as education, training, employment and other activities to aid rehabilitation has become 
increasingly limited in recent years.  Only one in seven people said they spent 10 hours or more 
out of their cell each day and almost one third of people (31%) held in local prisons said they 
spent less than two hours out of their cell each day (HM Chief Inspector of Prisons, 2016). 
Lower rates of drug use have been reported by people who spent more than ten hours a day out 
of the cells (HM Inspectorate of Prisons, 2015). Only 44% of prisons received a positive rating 
for purposeful activity work in 2015-2016 (HM Chief Inspector of Prisons, 2016). Moreover, 
the quality of education and training in prisons has been deteriorating (Ofsted, 2015; Taylor, 
2014) and prison inspectors found that much of the employment in prisons is mundane, 
repetitive and not linked to resettlement aims (HM Chief Inspector of Prisons, 2016). The 
ability to provide a purposeful regime has been affected by the chronic overcrowding, budget 
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cuts and staff shortages that have plagued the prison service over time (Ministry of Justice, 
2016b; NOMS, 2016; Ministry of Justice, 2016c).   
Prisons are increasingly described as brutal places where staff and prisoners feel unsafe 
with the highest rates of death, homicide, assaults, suicides, and self-harm ever recorded in the 
last five years (Ministry of Justice, 2016d).   When they enter prison, prisoners also have 
‘imported vulnerabilities’ (Maruna and Liebling, 2005) including histories of problematic drug 
and alcohol use, mental and physical health problems, high levels of deprivation, homelessness 
and poor coping skills (EMCDDA, 2012; WHO, 2014) which when combined with the 
detrimental prison environment characterized by overcrowding, understaffing and 
deteriorating buildings may encourage, sustain or exacerbate drug use (Wheatley, 2016). The 
current problem representation of NPS use as a law, order and control ‘problem’ masks the 
possibility that prisoners are using these substances as a response to these various pains of 
imprisonment, their imported vulnerabilities and the current conditions, culture and context of 
the prison environment.  It discounts these wider structural and economic issues within the 
prison setting as explanations and contributing factors.  Instead, this problematisation allows 
NPS use to be blamed for these conditions and further exacerbating them.   
These temporal and spatial aspects of drug use in prisons have clear parallels with 
Suzanne Fraser’s work on waiting for methadone maintenance treatment and the ways time 
and space co-produce each other as a chronotope of the queue which helps to produce particular 
methadone subjects (Fraser, 2006: 192).  Similarly, the harsh conditions of the prison space 
combined with the boredom, monotony, repetition and lack of meaning related to prison 
temporality could provide alternative explanations for the increases in prison violence, deaths 
and unrest, rather than this being directly caused by NPS. Here, violence and disorder are seen 
partly as the products of the particular spatio-temporal experiences of prison life.  Moreover, 
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the official view that NPS is directly linked to violence is based on a linear expression of cause 
and effect.  In order to counter this simplistic view, it is useful to draw on the account put 
forward by Race (2014) of ‘emergent causality’ to demonstrate how causation is emergent and 
bound up with space and time.  Crackdowns on NPS use in prisons position deterrence as a 
direct and uni-directional effect; however, such an approach cannot account for the more 
complex dynamics or interplay between space, time and various unforeseen consequences and 
harms.  It is important to explore the multiple objects and practices that contribute to the 
shaping of drugs in prison contexts.   
NPS use in prisons could also be constituted as a demand ‘problem’ in which the 
response would be to provide more prevention, treatment, rehabilitation, and harm reduction 
initiatives.  As we have seen through both the current and historical responses, this 
problematization has been secondary to the dominant law, order and control one.  The 
development of prevention, treatment and harm reduction responses has been patchy and ad 
hoc compared to the universal provision involved in the regulatory response.  Although the 
PHE toolkit aims to provide prison-based staff with information and guidance around dealing 
with the use of NPS in prisons, there are no universal treatment or harm reduction initiatives 
specifically targeting NPS at present in prisons.  As in the community, the health approaches 
recommended in prison have been mainly to apply and adapt existing effective drugs 
interventions to NPS (PHE, 2015; EMCDDA, 2016a).  A number of individual drug agencies 
have been developing innovative responses to NPS in prisons where they deliver services.  For 
example, RAPT has appointed a person to lead on NPS in the prisons they work and established 
NPS working groups which involve prison management, healthcare and substance use teams 
(RAPT, 2015).  The HM Inspectorate of Prisons (2015: 56) observed examples of ‘effective 
peer-led education’ on NPS, ‘whereby well-trained and well-supervised prisoners provided 
effective education to other prisoners’ in three prisons. Peer support and ‘experts by 
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experience’ in NPS are also mentioned as part of the consultancy services, advice, and training 
offered by the treatment agency, Change, Grow, Live (CGL, 2016).  In February 2017, HM 
Prison Forest Bank issued a harm reduction leaflet to prisoners which details 11 safety rules 
for taking NPS in prison including beginning with a small amount, chopping powders finely 
prior to snorting, not sharing needles if injecting, using one drug at a time, not using alone and 
instructions on how to help someone who has taken NPS including how to place someone in 
the recovery position. 
In contrast to the regulatory response, treatment, prevention and harm reduction have 
been slow in developing both in the prison and the community and there is no universal 
provision across the prison system as a whole.  As evidenced in some of the examples above, 
although the demand problematization is present in some prisons, it co-exists within an 
overarching problematization of NPS being a law, order and control ‘problem’.  This constrains 
the development of innovative responses that would help to reduce the harm to those using 
these substances. 
Bacchi (2009) argues that the alternative problem representations put forward by 
analysts also need to be subjected to critical interrogation in order to explore their underlying 
assumptions and constitutive effects.  When producing NPS as a regime ‘problem’, the 
underlying assumption is that people in prison should be leading productive, purposeful and 
meaningful lives and that they should be making active contributions, reparation and earning 
their keep while in custody.  Moreover, rather than problematizing NPS as a response to the 
various ‘pains of imprisonment’ as argued above, an alternative reading may be that people 
choose to use NPS and other drugs in prison for pleasure and derive social benefits through use 
such as interactions with others (Crewe, 2005; 2006; Mjaland, 2016).  Drug policy debates are 
dominated by concerns about the risk and harms associated with use and ignore the pleasures 
  23 
associated with intoxication (Duff, 2008; Duncan et al, 2017).  Similarly, the discourse of 
pleasure is rarely acknowledged in prison policy.  Recognising the pleasurable and social 
aspects of drug use may help to develop interventions which reduce the incidence of drug-
related harm and provide activities which offer alternative sources of pleasure. 
 
Conclusion:  moving toward multiple representations of the ‘problem’  
Bacchi’s WPR approach does not analyse ‘problems’ and ‘solutions’ separately, but 
begins with a postulated solution and identifies the problem representation implicit within it 
(Bacchi, 2009; 2012a).  By analyzing the policy reactions to NPS in prisons, it is possible to 
determine how the ‘problem’ has been constituted.  NPS has been represented predominantly 
as a ‘problem’ of supply and lack of control, with the aim of the policy to eradicate the supply 
and deter those who use the substances through the threat of punishments and applying 
technology, such as testing and enhanced detection initiatives. The emphasis on regulation 
through testing and punishment implies that prisoners using these substances are ‘risky’ groups 
that need to be managed and controlled.  If they do not conform to the new rules and 
regulations, then they will be punished.  The current representation of the ‘problem’ blames 
the volatility of the substances and the individual prisoners who use them as the main causes 
of the current prison ‘crisis’, rather than as consequences of the wider culture, context and 
conditions. It has diverted attention away from the more intractable problems within prisons 
such as budget cuts, decreasing staff levels, overcrowding, cuts to services and provision, lack 
of purposeful activities and increasing levels of violence, self-harm and suicide.  In effect, NPS 
have been conveniently scapegoated for more fundamental and systemic problems within the 
prison system that have much longer histories and provide the platform for arguing for more 
resources to deal with the wider ‘crisis’. 
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The Ministry of Justice has been actively engaged in producing drugs and NPS in 
prisons as a law, order and control ‘problems’.  This constitution of the ‘problem’ is important 
because it impacts on the processes, practices and resources for governing people who use 
these substances in prisons.  This problem representation can be traced back to the early 1990s 
and has become embedded and reproduced in policy and practice over time.  A key difference 
between the mid-1990s and the current period is that in 1995 there was a dedicated policy 
document outlining the various elements of the prison drugs strategy and a review process 
based on commissioned research.  After the review of the 1995 strategy, the revised 1998 
strategy was re-balanced to focus more on treatment and rehabilitation. From the response to 
NPS in prisons thus far, there appears to have been no learning from the previous problem 
representations that resulted in imbalances in prison drug policy which were subsequently 
altered through greater emphasis on demand reduction.  Although it may appear difficult to 
disrupt these entrenched problem representations, Bacchi’s framework provides a method to 
allow those involved in the development of policy to construct counter discourses or alternative 
problematisations.  For policy workers, it ‘creates the possibility to think otherwise’ (Bacchi 
and Goodwin, 2016: 108). 
In the current phase of policy, the HM Inspectorate of Prisons (2015), which provides 
independent scrutiny of prison conditions and treatment of prisoners, recommends a whole 
system approach to drugs in prisons which includes both supply reduction and demand 
reduction. This recognizes more than one problem representation around the issue.  In 
particular, it places emphasis on reducing the demand for these substances by addressing wider 
issues that may lead to substance use including action to reduce violence and bullying, 
provision of purposeful activity to reduce boredom and promote better sleep patterns, and 
access to health care to provide effective pain management, dental care and hospital 
appointments, thus reducing the demand for self-medication.  The Inspectorate advocates that 
  25 
treatment for drugs and NPS should include a range of measures including substitute 
prescribing, psychosocial interventions and harm reduction.  Rather than being based on a 
single representation of the ‘problem’ of NPS in prisons, this type of strategy would need to 
emerge from multiple representations of the ‘problem’. It acknowledges that the institution is 
also responsible for dealing with the ‘problem’ not just through regulation and control, but also 
by improving the conditions, regime and provision of services in prisons which lead prisoners 
to use substances to escape from the current realities of their imprisonment.  
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TABLE 1:  Timeline of Key Documents relating to the Response to NPS in Prisons 2015-
2016 
Date Document 
January 2015 Ministry of Justice Press Release, New crackdown on dangerous legal 
highs in prison (2 pages) 
February 2015 Criminal Justice and Courts Act 2015 – allows mandatory drug testing for 
non-controlled substances in prisons 
March 2015 Serious Crime Act 2015 – makes it an offence to throw any object into 
prisons, including drugs and other substances 
December 2015 Public Health England – New psychoactive substances (NPS) in prisons: 
a toolkit for prison staff (34 pages) 
May 2016 Psychoactive Substances Act 2016 – restrictions on production, sale and 
supply of NPS and possession in prisons becomes an offence. 
November 
2016 
Ministry of Justice, White Paper on Prison Safety and Reform (61 pages) 
 
 
 
 
